{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:18:13Z","timestamp":1778872693530,"version":"3.51.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1093\/ndt\/gfs417","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T20:11:21Z","timestamp":1354738281000},"page":"380-385","source":"Crossref","is-referenced-by-count":58,"title":["Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease"],"prefix":"10.1093","volume":"28","author":[{"given":"Imed","family":"Helal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"McFann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godela M.","family":"Fick-Brosnahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"key\n\t\t\t\t20170518085720_GFS417C1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C2","first-page":"502","article-title":"Polycystic kidney disease","volume-title":"Diseases of the Kidney and Urinary Tract","author":"Ecder","year":"2007","edition":"8th edn"},{"key":"key\n\t\t\t\t20170518085720_GFS417C3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of with autosomal dominant polycystic kidney disease","volume":"6","author":"Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518085720_GFS417C6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.00360110","article-title":"Early renal abnormalities in autosomal dominant polycystic kidney disease","volume":"5","author":"Meijer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","article-title":"Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease","volume":"27","author":"Orskov","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518085720_GFS417C11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.183244","article-title":"Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999\u20132006","volume":"59","author":"Loeffler","year":"2012","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170518085720_GFS417C12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","article-title":"Hyperuricemia and incidence of hypertension among men without metabolic syndrome","volume":"49","author":"Krishnan","year":"2007","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170518085720_GFS417C13","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518085720_GFS417C14","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518085720_GFS417C15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"Weiner","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.ajkd.2010.01.019","article-title":"Association of uric acid with change in kidney function in healthy normotensive individuals","volume":"56","author":"Bellomo","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C17","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ndt\/gfr530","article-title":"Serum uric acid and chronic kidney disease: the Severance cohort study","volume":"27","author":"Mok","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518085720_GFS417C18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170518085720_GFS417C20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin\u2013angiotensin\u2013aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518085720_GFS417C21","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","article-title":"The intrarenal renin\u2013angiotensin system in autosomal dominant polycystic kidney disease","volume":"287","author":"Loghman-Adham","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C22","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2012.05.004","article-title":"Pathway analysis of genome-wide association studies on uric acid concentrations","author":"Lee","year":"2012","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170518085720_GFS417C24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","article-title":"Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study","volume":"39","author":"Fick-Brosnahan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-4-431-66996-8_46","article-title":"Estimating mediated effects with survival data","volume-title":"New Developments on Psychometrics","author":"Tein","year":"2003"},{"key":"key\n\t\t\t\t20170518085720_GFS417C26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol Methods"},{"key":"key\n\t\t\t\t20170518085720_GFS417C27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin\u2013angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170518085720_GFS417C28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","article-title":"Oxidative stress with an activation of the renin\u2013angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction","volume":"28","author":"Yu","year":"2010","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170518085720_GFS417C29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170518085720_GFS417C30","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00326.x","article-title":"Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease","volume":"64","author":"King","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518085720_GFS417C31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM197111252852205","article-title":"Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. 1","volume":"285","author":"Schrier","year":"1971","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518085720_GFS417C32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM197112022852305","article-title":"Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. 2","volume":"285","author":"Schrier","year":"1971","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518085720_GFS417C33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518085720_GFS417C34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.35.3.746","article-title":"Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension","volume":"35","author":"Butler","year":"2000","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170518085720_GFS417C35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1681\/ASN.2010111185","article-title":"Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease","volume":"22","author":"Kao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C36","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.11451210","article-title":"A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function","volume":"6","author":"Kanbay","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.ajkd.2007.09.020","article-title":"Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease","volume":"51","author":"Wang","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2215\/CJN.02330607","article-title":"Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries","volume":"3","author":"Turkmen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C40","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C41","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1992.413","article-title":"Renal histology in polycystic kidney disease with incipient and advanced renal failure","volume":"42","author":"Zeier","year":"1992","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518085720_GFS417C42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease","volume":"6","author":"Menon","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C44","doi-asserted-by":"crossref","DOI":"10.1007\/s10157-012-0609-3","article-title":"Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy","author":"Omori","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518085720_GFS417C46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C47","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C48","doi-asserted-by":"crossref","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","article-title":"Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"299","author":"Yamaguchi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170518085720_GFS417C49","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000334166","article-title":"Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects","volume":"120","author":"Chang","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170518085720_GFS417C50","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518085720_GFS417C51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/28\/2\/380\/12849344\/gfs417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T12:39:42Z","timestamp":1643805582000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfs417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,4]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,4]]},"published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfs417","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,4]]}}}